The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
CAR-T Meeting 2021 | Implementation of CAR T-cell therapy in myeloma: practical and patient-related aspects
Maria-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, outlines the practical and patient-related aspects that need to be considered for the implementation of CAR T-cell therapy in multiple myeloma. In order to select the appropriate therapy for each patient, physicians need to consider different criteria, such as disease morbidity, treatment history, organ function, familiar and social support and quality of life. This interview took place during the 3rd European CAR T-cell Meeting.
